| FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer P Paulo, JD Barros‐Silva, FR Ribeiro, J Ramalho‐Carvalho, C Jerónimo, ... Genes, Chromosomes and Cancer 51 (3), 240-249, 2012 | 105 | 2012 |
| MicroRNA-375 plays a dual role in prostate carcinogenesis P Costa-Pinheiro, J Ramalho-Carvalho, FQ Vieira, J Torres-Ferreira, ... Clinical epigenetics 7, 1-14, 2015 | 103 | 2015 |
| Deregulated expression of selected histone methylases and demethylases in prostate carcinoma FQ Vieira, P Costa-Pinheiro, J Ramalho-Carvalho, A Pereira, ... Endocrine-related cancer 21 (1), 51-61, 2014 | 103 | 2014 |
| Impaired DICER1 function promotes stemness and metastasis in colon cancer MS Iliou, V da Silva-Diz, FJ Carmona, J Ramalho-Carvalho, H Heyn, ... Oncogene 33 (30), 4003-4015, 2014 | 102 | 2014 |
| Circulating microRNAs as biomarkers for prostate cancer detection and metastasis development prediction D Bidarra, V Constâncio, D Barros-Silva, J Ramalho-Carvalho, ... Frontiers in oncology 9, 900, 2019 | 82 | 2019 |
| Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells I Graça, E J Sousa, T Baptista, M Almeida, J Ramalho-Carvalho, ... Current pharmaceutical design 20 (11), 1803-1811, 2014 | 76 | 2014 |
| Study of ATLAS sensitivity to FCNC top decays J Carvalho, N Castro, L Chikovani, T Djobava, J Dodd, S McGrath, ... The European Physical Journal C 52, 999-1019, 2007 | 76 | 2007 |
| MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors J Torres-Ferreira, J Ramalho-Carvalho, A Gomez, FD Menezes, R Freitas, ... Molecular Cancer 16, 1-12, 2017 | 66 | 2017 |
| Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1 J Ramalho-Carvalho, JB Martins, L Cekaite, A Sveen, J Torres-Ferreira, ... Cancer letters 385, 150-159, 2017 | 65 | 2017 |
| Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer JR Carvalho, L Filipe, VL Costa, FR Ribeiro, AT Martins, MR Teixeira, ... Apoptosis 15, 956-965, 2010 | 60 | 2010 |
| Cysteine-Rich Secretory Protein-3 (CRISP3) Is Strongly Up-Regulated in Prostate Carcinomas with the TMPRSS2-ERG Fusion Gene FR Ribeiro, P Paulo, VL Costa, JD Barros-Silva, J Ramalho-Carvalho, ... PloS one 6 (7), e22317, 2011 | 58 | 2011 |
| High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer J Lobo, A Rodrigues, L Antunes, I Graca, J Ramalho-Carvalho, FQ Vieira, ... Urologic Oncology: Seminars and Original Investigations 36 (4), 161. e7-161. e17, 2018 | 57 | 2018 |
| Downregulation of miR-130b~ 301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer J Ramalho-Carvalho, I Graça, A Gomez, J Oliveira, R Henrique, M Esteller, ... Journal of hematology & oncology 10, 1-13, 2017 | 57 | 2017 |
| Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer D Almeida-Rios, I Graça, FQ Vieira, J Ramalho-Carvalho, E Pereira-Silva, ... Oncotarget 7 (33), 53018, 2016 | 52 | 2016 |
| High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions AT Martins, P Monteiro, J Ramalho-Carvalho, VL Costa, M Dinis-Ribeiro, ... Breast cancer research and treatment 129, 1-9, 2011 | 49 | 2011 |
| A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97 J Ramalho-Carvalho, CS Gonçalves, I Graça, D Bidarra, E Pereira-Silva, ... Clinical epigenetics 10, 1-15, 2018 | 48 | 2018 |
| Epigenetic regulation of Wnt signaling pathway in urological cancer VL Costa, R Henrique, FR Ribeiro, JR Carvalho, J Oliveira, F Lobo, ... Epigenetics 5 (4), 343-351, 2010 | 46 | 2010 |
| Analysis of the UDP-glucuronosyltransferase gene in Portuguese patients with a clinical diagnosis of Gilbert and Crigler–Najjar syndromes E Costa, E Vieira, M Martins, J Saraiva, E Cancela, M Costa, R Bauerle, ... Blood Cells, Molecules, and Diseases 36 (1), 91-97, 2006 | 45 | 2006 |
| Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma S Duarte-Pereira, F Paiva, VL Costa, J Ramalho-Carvalho, ... European journal of cancer 47 (7), 1106-1114, 2011 | 42 | 2011 |
| Altered Expression of MGMT in High-Grade Gliomas Results from the Combined Effect of Epigenetic and Genetic Aberrations J Ramalho-Carvalho, M Pires, S Lisboa, I Graca, P Rocha, ... PLoS One 8 (3), e58206, 2013 | 41 | 2013 |
